Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Dossier - 30/08/2010 12119_de.jpg

    Disease prevention through better diagnostics

    “Classical treatment approaches are not the only way to ensure good health, rehabilitation and care. In fact, it is envisaged that more effective prevention will contribute to halting the development of diseases and maintaining good health. Prevention is designed to prevent health risks and diseases, make them less likely and delay their onset.” (Declaration of the German government; Official Records of Parliament 17/845, 26th February 2010)

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/disease-prevention-through-better-diagnostics
  • Article - 30/08/2010 12175_de.jpg

    A centre focusing on hepatocellular carcinoma research

    Under its director, Prof. Dr. Peter Schirmacher, the Institute of Pathology at the University of Heidelberg has become a major liver cancer research centre, with a particular focus on hepatocellular carcinoma. The institute is looking for new diagnostic markers and new molecular targets for drugs that have the potential to be used for specifically treating this cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-centre-focusing-on-hepatocellular-carcinoma-research
  • Article - 30/08/2010 12218_de.jpg

    Bodensee Brustzentrum offers effective breast cancer prevention services

    The two Brustzentrum Bodensee (Lake Constance Breast Centre) sites at the Hospital in Constance and the Women’s Hospital in Friedrichshafen have a principal goal: to enable the best possible early detection of all types of breast cancer, to reduce the morbidity and mortality of breast cancer patients and to increase survival rates by offering ultra-modern breast cancer prevention measures.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bodensee-brustzentrum-offers-effective-breast-cancer-prevention-services
  • Article - 30/08/2010 12172_de.jpg

    Diagnostics for the early detection of cervical cancer

    The Pap test is regarded as the most successful test for cancer ever, and has saved the lives of many women. However, the test is associated with several weaknesses. The Heidelberg-based in vitro diagnostics company mtm laboratories AG develops and commercialises highly sensitive and highly specific immunochemical tests that provide greater reliability. These tests have the potential to revolutionise the early detection of cervical cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/news/diagnostics-for-the-early-detection-of-cervical-cancer
  • Article - 30/08/2010 12096_de.jpg

    Genetic testing for the prevention of diseases?

    Genetic testing is beginning to play an important role in personalised medicine and is indispensable for the diagnosis and therapy of many diseases. However, the preventive and diagnostic power of many genetic tests is still inferior to traditional diagnostic tests. In addition, commercial genetic tests do not always live up to the claims made about them.

    https://www.gesundheitsindustrie-bw.de/en/article/news/genetic-testing-for-the-prevention-of-diseases
  • Article - 30/08/2010 12228_de.jpg

    More effective prevention and treatment of diabetic feet

    Dr. med. dent. Hans-Helmut Schmidt has developed a device that enables the effective and hygienic treatment of patients with diabetic foot syndrome DFS. The new device known as DIAPEDES enables diabetic feet to be treated in a closed foot-shaped container under definite clinical conditions. Diabetic feet can smell and look quite unpleasant and the preventive care that this device will offer for many users has been developed with this problem in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/more-effective-prevention-and-treatment-of-diabetic-feet
  • Article - 09/08/2010 The schematic shows how blood samples are collected on paper.

    Quick and early detection of rare diseases

    Lysosomal storage diseases LSD are a group of around 50 rare inherited metabolic disorders. Only 12 LSDs have been described biochemically and microbiologically. Prof. Dr. Michael Przybylski from the Steinbeis Transfer Centre for Biopolymer Analysis and Proteomics at the University of Constance now hopes to change this situation. In a project carried out in cooperation with the biotech company Genzyme CEE Konstanz and the University of Timisoara…

    https://www.gesundheitsindustrie-bw.de/en/article/news/quick-and-early-detection-of-rare-diseases
  • Press release - 05/07/2010 AnDiaTec Logo

    AnDiaTec - Real cowboys have heard of Kornwestheim

    AnDiaTec GmbH & Co. KG from Kornwestheim is in high demand worldwide as a partner specialising in detection methods for bacteria and viruses. The company is a world market leader in real time PCR Kits for the detection of noroviruses. The U.S. Ministry of Agriculture even draws on the expertise of AnDiaTec in relation to virus infections in cattle. After an intensive period of research and development, the company is now expanding its sales…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/andiatec-real-cowboys-have-heard-of-kornwestheim
  • Article - 28/06/2010 The schematic shows a protein complex with different areas.<br />

    ATG:biosynthetics GmbH – Modular molecular systems of the future

    ATGbiosynthetics GmbH based in Merzhausen close to Freiburg produces biological systems that can combine gene constituents following a construction kit principle. The company provides the pharmaceutical industry and basic researchers with products that have specifically chosen properties.

    https://www.gesundheitsindustrie-bw.de/en/article/news/atg-biosynthetics-gmbh-modular-molecular-systems-of-the-future
  • Press release - 24/06/2010 08495_de.jpg

    febit Announces Operational Restructuring

    febit today announced a restructuring as a consequence of its strategic focus on blood-based microRNA biomarker discovery febits major business development in 20092010 and on partnerships and intellectual property IP commercialization. The new focus includes the collaboration and provision of high-end services for clinical researchers in academia diagnostic companies and the pharma industry. The operational restructuring resulted in a reduction…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/febit-announces-operational-restructuring
  • Press release - 07/06/2010

    Addition of renowned experts to Medical Advisory Board and achievement of international quality standards generate added optimism

    With a € 1.5 Mio Second Closing, Curetis has now increased its Series A financing round to € 20 Mio. This additional financing will enable Curetis to complete the development of its innovative diagnostic products through to market entry. Quality Certification for its diagnostic product development represents an additional milestone in Curetis' commercial strategy. At the same time, Curetis has added internationally recognized expertise in…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/addition-of-renowned-experts-to-medical-advisory-board-and-achievement-of-international-quality-stan
  • Article - 07/06/2010 11503_de.jpg

    Biametrics – specialist in label-free bioanalysis

    Biametrics is a spin-off from the University of Tübingen that focuses on the commercialisation of innovative developments in the field of label-free bioanalyses. The companys platform detects interactions between biomolecules using reflectometric interference spectroscopy RIfS and can be integrated into small mobile analytical devices.

    https://www.gesundheitsindustrie-bw.de/en/article/news/biametrics-specialist-in-label-free-bioanalysis
  • Press release - 21/05/2010 Heiko Möller standing in front of an NMR spectrometer.

    The fingerprints of molecules

    Prof. Heiko Möller is head of the NMR Core Facility a centre at the University of Constance that focuses on magnetic resonance spectroscopy where fingerprints of molecules are taken. The highly sensitive analysis instruments are used by his group of researchers for research projects on subjects ranging from severed visual nerves cancer protection and the rapid identification of anthrax bacteria.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/the-fingerprints-of-molecules
  • Article - 10/05/2010 11348_de.jpg

    CeGaT: DNA and RNA sequencing specialist

    Sequencing service providers are facing new challenges due to the enormous technological progress made in this field. The market requires technically feasible solutions reliable and rapid sequence analyses in which entire genomes can be analysed within a couple of days or weeks. This can only be achieved with state-of-the-art high-throughput technologies. Tübingen-based CeGaT GmbH has been offering DNA and RNA sequencing using state-of-the-art…

    https://www.gesundheitsindustrie-bw.de/en/article/news/cegat-dna-and-rna-sequencing-specialist
  • Article - 07/05/2010 11268_de.jpg

    Günter Gauglitz: research at the boundaries of physics, chemistry and biology

    Biosensors and label-free optical bioanalysis are the major research priorities of Prof. Dr. Günter Gauglitz from the Institute for Physical and Theoretical Chemistry IPC at the University of Tübingen. His whole career has been about the acquisition of multi-million third-party funded projects that are worked on by a team of 15 scientists at the IPC.

    https://www.gesundheitsindustrie-bw.de/en/article/news/guenter-gauglitz-research-at-the-boundaries-of-physics-chemistry-and-biology
  • Press release - 06/05/2010 08495_de.jpg

    Second Biomarker Expert Meeting in Heidelberg

    Numerous experts in molecular diagnostics convened at the Second Workshop of the Biomarker Discovery Center (BDC) in Heidelberg. More than 40 researchers from universities, hospitals and industry from various regions of Germany made their way to the city despite adverse travel conditions caused by the volcanic ash cloud.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/second-biomarker-expert-meeting-in-heidelberg
  • Press release - 23/04/2010 Logo DKFZ, blue letters "DKFZ"

    International Cancer Genome Project Publishes Article in Nature

    Information obtained in the various projects of the International Cancer Genome Consortium may soon be used to the benefit of cancer patients worldwide because the data will be freely accessible and not patentable. The project thus aims to make sure that the molecular data of the various tumor types can be used as swiftly as possible for new diagnostic methods or therapies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/international-cancer-genome-project-publishes-article-in-nature
  • Press release - 22/04/2010 The photo shows the cover of the report: "Die deutsche Biotechnologie-Branche 2010".

    Biotechnology is a driver of economic growth

    The latest economic figures on biotechnology were presented at the German Biotechnology Days held in Berlin on 21st and 22nd April 2010. The figures show that German biotechnology companies have not lost their innovation power despite the global financial crisis. In 2009 the companies RD expenditures of around one billion euros remained at a similar high level to the previous year. The biotechnology industry is creating new jobs despite the…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/biotechnology-is-a-driver-of-economic-growth
  • Article - 19/04/2010 Scientist in the laboratory of Przybylski's reserach group at the University of Constance holding a test tube in her hand and standing in front of an analysis device.

    Natural antibodies to treat Alzheimer’s

    Alzheimers disease is characterised by changes in the substance and structure of the brain that are caused by the depositing of protein plaques in the brain. Prof. Michael Przybylski and his team of researchers at the University of Constance have deciphered the structure of the site where mouse antibodies attach to the plaques subsequently causing them to dissolve. These findings will now be used to identify the binding structure of a component…

    https://www.gesundheitsindustrie-bw.de/en/article/news/natural-antibodies-to-treat-alzheimer-s
  • Article - 15/04/2010 11122_de.jpg

    Rainer Wittig: oxygen biology opens up new paths

    “When one talks about light in the field of biology, the crucial role played by oxygen often comes into it.” When Rainer Wittig says that he sees himself as an oxygen researcher, he is not just simplifying his job title because essentially, that is exactly what he is. A lot of the molecular biologist’s work revolves around oxygen, in particular its highly reactive forms. Wittig has been head of the biology department at the Ulm-based ILM since…

    https://www.gesundheitsindustrie-bw.de/en/article/news/rainer-wittig-oxygen-biology-opens-up-new-paths
  • Press release - 30/03/2010 10972_de.jpg

    Mediagnost GmbH - successfull since 25 years

    Mediagnost Gesellschaft für Forschung und Herstellung von Diagnostika GmbH in Reutlingen is one of the oldest biotechnology companies in Germany. Mediagnost offers a broad range of services including the production of antibodies proteins and viruses the analysis of samples and the customisation of raw materials. The company celebrated its 25th anniversary on 19th March 2010 with a series of events.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mediagnost-gmbh-successfull-since-25-years
  • Press release - 26/03/2010 10875_de.jpg

    Restarting the muscular engine – Research Prize awarded to two medical practitioners from Ulm and Heidelberg

    Dr. Karin Jurkat-Rott, associate professor at the Institute of Applied Physiology at the University of Ulm, and Dr. Marc-André Weber, associate professor and chief physician in the Department of Radiology at the Heidelberg University Hospital, were awarded the Eva Luise Köhler Research Prize for Rare Diseases in Berlin on 1st March 2010. The prize was awarded by Luise Köhler in the presence the German Federal President Horst Köhler, the German…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/restarting-the-muscular-engine-research-prize-awarded-to-two-medical-practitioners-from-ulm-and-heid
  • Article - 22/03/2010 10931_de.jpg

    IBR Inc.: Dual strategy for safe and effective drugs

    IBR Inc. a science-based provider of preclinical and clinical services specialises in inflammatory diseases. The analyses it carries out for the pharmaceutical and biotech sector help exclude potential side effects of specific drug candidates early in the development process.

    https://www.gesundheitsindustrie-bw.de/en/article/news/ibr-inc-dual-strategy-for-safe-and-effective-drugs
  • Press release - 12/03/2010 logo of mtm

    mtm laboratories announces the European launch of CINtec® PLUS

    mtm laboratories, a privately held diagnostics company from Heidelberg, Germany, announced the launch of CINtec® PLUS, the company’s next generation cervical cancer screening product with unmatched accuracy for the screening and management for cervical cancer. CINtec® PLUS will be launched with claims direct in Germany, Italy, Spain, France and the UK, and will also be available in other parts of the world via mtm’s nominated distributors.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mtm-laboratories-announces-the-european-launch-of-cintec-plus
  • Press release - 04/03/2010 10810_de.jpg

    New German-Austrian project for breast cancer therapy

    Hope for breast cancer patients under the leadership of the Vorarlberg Institute for Vascular Investigation and Treatment VIVIT a cross border cooperation is to start between hospitals and bioanalytical laboratories of the Rhine Valley and Lake Constance region. It is aimed at exploring the influence genetic material DNA has on the progression of breast cancer and the response to breast cancer treatment. A collaboration which became possible…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-german-austrian-project-for-breast-cancer-therapy

Page 13 / 17

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search